跳至主要内容
临床试验/ACTRN12619000352101
ACTRN12619000352101终止未知

Salt ALTernatives Study (SALTS): A randomised controlled trial to determine the effects of a 12-week dietary salt reduction intervention (SaltSwitch app + dietary alternative salt) on systolic blood pressure in adults with high blood pressure

ational Institute for Health Innovation0 个研究点目标入组 168 人开始时间: 2019年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aged 18 years or older
  • Own a smartphone (iPhone or Android)
  • Have a systolic blood pressure of greater than or equal to 140mmHg and/or diastolic blood pressure of greater than or equal to 85mmHg at screening
  • Are willing to contribute to grocery shopping during the study period
  • Are able to read and understand English

排除标准

  • Currently use a dietary alternative salt
  • Currently use the FoodSwitch smartphone app
  • Have a contraindication to changing dietary sodium intake e.g. severe kidney disease or use of a potassium sparing diuretic
  • Are taking medication that may lead to hyponatraemia or acute build-up of body water such as furosemide, regular NSAID use, or regular prednisone use
  • Have had a stroke or cardiovascular event (hospitalisation for heart attack, coronary artery revascularisation (CABG or stenting), stroke or heart failure) in the previous 6 months
  • Have diagnosed heart failure
  • Do not provide at least six home-based blood pressure measures during week two of baseline (week -2)
  • Do not return a spot (casual) urine sample at week -1 of baseline
  • Are planning on going away for two or more weeks over the next 14 weeks
  • Are unable to provide informed consent

研究者

发起方
ational Institute for Health Innovation

相似试验